Literature DB >> 25296074

Outcomes on quality of life, weight loss, and comorbidities after Roux-en-Y gastric bypass.

Roberto Coelho Netto da Cunha Costa1, Nagamassa Yamaguchi1, Marco Aurelio Santo2, Daniel Riccioppo2, Paulo Engler Pinto-Junior1.   

Abstract

CONTEXT: Bariatric surgery has become the most effective method for producing weight loss in obese patients. The evaluation of improvement of comorbidities and changes in the quality of life are important outcome factors; however, it is necessary to investigate whether they persist over the long term.
METHODS: A cross-sectional study was conducted on 143 obese patients from our institution from February 2007 to February 2008. These patients were divided into five independent groups, one being a control group, plus four other groups with 1, 2, 3, 4 or more years following surgical Roux-en-Y gastric bypass with a silicon ring banded. quality of life forms and anthropometric measurements were performed and its scores correlated with social factors, weight loss success, and status of obesity-related conditions.
RESULTS: For the group that was 1 year postoperative, a significant percentage of excess body weight loss (EBWL%) of 81.7% was observed. The groups with 2, 3, 4 or more years of post-surgical follow-up showed a EBWL decline, but without significant difference. The main comorbidity percentages in all patients who had the surgery was as follows: 69.7% for hypertension; 88.2% for diabetes mellitus; and 27.5% for arthropathy. There was a significant decrease in the rate for diabetes resolution (P = 0.035) observed by evolutionary assessment of the comorbidity resolution. The results obtained by BAROS were good, very good, or excellent in more than 96% of patients in all evaluations that were performed. The use of the Moorehead-Ardelt Questionnaire (M/A) demonstrated improvement in the quality of life. Moreover, the quality of life, when evaluated through SF-36, also showed improvement in all related areas after 1 year; however, after 4 years, improvement remained elevated only in the areas of general state of health and functional capacity.
CONCLUSIONS: The Roux-en-Y gastric bypass procedure was able to achieve EBWL of 81.7% after 1 year following surgery, remaining steady with little decline after this period. Important resolution of comorbidities, such as hypertension and diabetes, was also seen. Immediate surgical outcomes assessed by SF-36 and M/A in the area of quality of life were satisfactory, but the general state of health and functional capacity areas were sustained satisfactory at a later time only.

Entities:  

Mesh:

Year:  2014        PMID: 25296074     DOI: 10.1590/s0004-28032014000300002

Source DB:  PubMed          Journal:  Arq Gastroenterol        ISSN: 0004-2803


  13 in total

1.  Physical Function, Quality of Life, and Energy Expenditure During Activities of Daily Living in Obese, Post-Bariatric Surgery, and Healthy Subjects.

Authors:  Fabiane Monteiro; Diego A N Ponce; Humberto Silva; Fabio Pitta; Alexandre J F Carrilho
Journal:  Obes Surg       Date:  2017-08       Impact factor: 4.129

2.  Adherence to Mediterranean Diet or Physical Activity After Bariatric Surgery and Its Effects on Weight Loss, Quality of Life, and Food Tolerance.

Authors:  Anna Gils Contreras; Anna Bonada Sanjaume; Nerea Becerra-Tomás; Jordi Salas-Salvadó
Journal:  Obes Surg       Date:  2020-02       Impact factor: 4.129

3.  Comparison of the efficacy of standard bariatric surgical procedures on Saudi population using the bariatric analysis and reporting outcome system.

Authors:  Azzam Al Kadi; Zakaur R Siddiqui; Arshad M Malik; Mohammed Al Naami
Journal:  Saudi Med J       Date:  2017-03       Impact factor: 1.484

4.  Patient-reported quality of life after bariatric surgery: a single institution analysis.

Authors:  Andrew J Vegel; Neil Shah; Anne O Lidor; Jacob A Greenberg; Ying Shan; Xing Wang; Luke M Funk
Journal:  J Surg Res       Date:  2017-06-15       Impact factor: 2.192

5.  Differences in Health-Related Quality of Life After Gastric Bypass Surgery: a Cross-Sectional Study.

Authors:  Tobias Antonsson; André Wennersten; Kaisa Sörensen; Sara Regnér; Mikael Ekelund
Journal:  Obes Surg       Date:  2021-04-30       Impact factor: 4.129

Review 6.  Glucagon-like peptide 1 in the pathophysiology and pharmacotherapy of clinical obesity.

Authors:  Ananthi Anandhakrishnan; Márta Korbonits
Journal:  World J Diabetes       Date:  2016-12-15

7.  Validation of a new method for the endoscopic measurement of post-bariatric gastric outlet using a standard guidewire: an observer agreement study.

Authors:  Luiz Gustavo de Quadros; Manoel Dos Passos Galvão Neto; Josemberg Marins Campos; Roberto Luiz Kaiser Junior; Eduardo Grecco; Mario Flamini Junior; Marcelo Falcao de Santana; Idiberto Jose Zotarelli Filho; Adriano Augusto Tomas Vasconcelos Almeida Alexandre
Journal:  BMC Res Notes       Date:  2017-01-03

8.  Quality of Life One Year After Bariatric Surgery: the Moderator Role of Spirituality.

Authors:  M Graça Pereira; Sara Faria; Helena Lopes
Journal:  Obes Surg       Date:  2019-04       Impact factor: 4.129

9.  ENDOSCOPIC SLEEVE GASTROPLASTY - MINIMALLY INVASIVE THERAPY FOR PRIMARY OBESITY TREATMENT.

Authors:  Manoel Dos Passos Galvão-Neto; Eduardo Grecco; Thiago Ferreira de Souza; Luiz Gustavo de Quadros; Lyz Bezerra Silva; Josemberg Marins Campos
Journal:  Arq Bras Cir Dig       Date:  2016

10.  BARIATRIC SURGERY IN THE ELDERLY: RESULTS OF A MEAN FOLLOW-UP OF FIVE YEARS.

Authors:  Denis Pajecki; Marco Aurelio Santo; Henrique Dametto Giroud Joaquim; Flavio Morita; Daniel Riccioppo; Roberto de Cleva; Ivan Cecconello
Journal:  Arq Bras Cir Dig       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.